BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26117990)

  • 1. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
    Ozegowska KE; Pawelczyk LA
    Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
    Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
    Dimitriadis GK; Kyrou I; Randeva HS
    Curr Pharm Des; 2016; 22(36):5535-5546. PubMed ID: 27464726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovaries and obesity.
    Messinis IE; Messini CI; Anifandis G; Dafopoulos K
    Best Pract Res Clin Obstet Gynaecol; 2015 May; 29(4):479-88. PubMed ID: 25487256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue dysfunction in polycystic ovary syndrome.
    Villa J; Pratley RE
    Curr Diab Rep; 2011 Jun; 11(3):179-84. PubMed ID: 21424395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.
    Teede HJ; Hutchison S; Zoungas S; Meyer C
    Endocrine; 2006 Aug; 30(1):45-53. PubMed ID: 17185791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome.
    Spritzer PM; Lecke SB; Satler F; Morsch DM
    Reproduction; 2015 May; 149(5):R219-27. PubMed ID: 25628442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
    Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
    Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of carbohydrate metabolism indices and adipocytokine profile and their relationship with androgens in polycystic ovary syndrome after menopause.
    Markopoulos MC; Valsamakis G; Kouskouni E; Boutsiadis A; Papassotiriou I; Creatsas G; Mastorakos G
    Eur J Endocrinol; 2013 Jan; 168(1):83-90. PubMed ID: 23076844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCOS in adolescence and type 2 diabetes.
    Carreau AM; Baillargeon JP
    Curr Diab Rep; 2015 Jan; 15(1):564. PubMed ID: 25398203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New markers of insulin resistance in polycystic ovary syndrome.
    Polak K; Czyzyk A; Simoncini T; Meczekalski B
    J Endocrinol Invest; 2017 Jan; 40(1):1-8. PubMed ID: 27473078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome in Polycystic Ovary Syndrome.
    Pasquali R
    Front Horm Res; 2018; 49():114-130. PubMed ID: 29894990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The metabolic aspects of polycystic ovarian syndrome].
    Skałba P; Dabkowska-Huć A
    Endokrynol Pol; 2005; 56(6):960-3. PubMed ID: 16821219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of leptin in polycystic ovary syndrome].
    Marciniak A; Starczewski A
    Pol Merkur Lekarski; 2008 Oct; 25(148):390-3. PubMed ID: 19145943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.